Literature DB >> 23604125

ING4 regulates a secretory phenotype in primary fibroblasts with dual effects on cell proliferation and tumor growth.

A Moreno1, I Soleto1, P García-Sanz2, G Moreno-Bueno2, I Palmero1.   

Abstract

ING proteins have an essential role in the control of a variety of cellular functions whose deregulation is associated with tumor formation and dissemination, such as proliferation, apoptosis, senescence or invasion. Accordingly, loss of function of ING proteins is a frequent event in many types of human tumors. In this report, we have studied the function of ING4, a member of the ING family of tumor suppressors, in the context of normal, non-transformed primary fibroblasts. We show that ING4 negatively regulates cell proliferation in this cell type. The antiproliferative action of ING4 requires its ability to recognize chromatin marks, it is p53-dependent at least in part, and it is lost in an ING4 cancer-associated mutant. Gene expression analysis shows that ING4 regulates the expression and release of soluble factors of the chemokine family. The secretory phenotype regulated by ING4 in primary fibroblasts displays a selective paracrine effect on proliferation, fostering the division of tumor cells, while inhibiting division in primary fibroblasts. Consistently, ING4-expressing fibroblasts promoted tumor growth in vivo in co-injection tumorigenesis assays. Collectively, our results show that ING4 not only can regulate the proliferation of primary non-transformed human fibroblasts, but also orchestrates a secretory phenotype in these cells that promotes tumor cell proliferation in vitro and in vivo. These findings support a critical role for ING4 expression in normal cells in the non-cell-autonomous regulation of tumor growth.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23604125     DOI: 10.1038/onc.2013.145

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

Review 1.  Inhibitor of Growth Factors Regulate Cellular Senescence.

Authors:  Soudeh Ghafouri-Fard; Mohammad Taheri; Aria Baniahmad
Journal:  Cancers (Basel)       Date:  2022-06-24       Impact factor: 6.575

Review 2.  INGs are potential drug targets for cancer.

Authors:  Runyun Zhang; Jianhua Jin; Juanjuan Shi; Yongzhong Hou
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-20       Impact factor: 4.553

Review 3.  Inhibitor of growth-4 is a potential target for cancer therapy.

Authors:  Shuping Yuan; Jianhua Jin; Juanjuan Shi; Yongzhong Hou
Journal:  Tumour Biol       Date:  2016-01-23

Review 4.  ING Proteins: Tumour Suppressors or Oncoproteins.

Authors:  Karine Jacquet; Olivier Binda
Journal:  Cancers (Basel)       Date:  2021-04-27       Impact factor: 6.639

5.  MicroRNA-199a and -214 as potential therapeutic targets in pancreatic stellate cells in pancreatic tumor.

Authors:  Praneeth R Kuninty; Linda Bojmar; Vegard Tjomsland; Marie Larsson; Gert Storm; Arne Östman; Per Sandström; Jai Prakash
Journal:  Oncotarget       Date:  2016-03-29

6.  ING4 Promotes Stemness Enrichment of Human Renal Cell Carcinoma Cells Through Inhibiting DUSP4 Expression to Activate the p38 MAPK/type I IFN-Stimulated Gene Signaling Pathway.

Authors:  Yu Tang; Xinyue Yang; Qing Wang; Haoyu Huang; Qinzhi Wang; Min Jiang; Chunluan Yuan; Yefei Huang; Yansu Chen
Journal:  Front Pharmacol       Date:  2022-04-14       Impact factor: 5.988

7.  Stromal ING1 expression induces a secretory phenotype and correlates with breast cancer patient survival.

Authors:  Satbir Thakur; Arash Nabbi; Alexander Klimowicz; Karl Riabowol
Journal:  Mol Cancer       Date:  2015-08-27       Impact factor: 27.401

8.  Delivery of inhibitor of growth 4 (ING4) gene significantly inhibits proliferation and invasion and promotes apoptosis of human osteosarcoma cells.

Authors:  Mei Li; Ye Zhu; Hongbin Zhang; Lihua Li; Peng He; Hong Xia; Yu Zhang; Chuanbin Mao
Journal:  Sci Rep       Date:  2014-12-09       Impact factor: 4.379

Review 9.  The essential role of tumor suppressor gene ING4 in various human cancers and non-neoplastic disorders.

Authors:  Yang Du; Yan Cheng; Guanfang Su
Journal:  Biosci Rep       Date:  2019-01-30       Impact factor: 3.840

10.  Inhibitor of Growth 4 (ING4) is a positive regulator of rRNA synthesis.

Authors:  Duc-Anh Trinh; Ryutaro Shirakawa; Tomohiro Kimura; Natsumi Sakata; Kota Goto; Hisanori Horiuchi
Journal:  Sci Rep       Date:  2019-11-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.